Literature DB >> 2149290

Cytoplasmic calcium and the relaxation of canine coronary arterial smooth muscle produced by cromakalim, pinacidil and nicorandil.

T Yanagisawa1, T Teshigawara, N Taira.   

Abstract

1. In order to investigate the vasodilator mechanisms of the K+ channel openers, cromakalim, pinacidil and nicorandil, we measured changes in cytoplasmic Ca2+ concentration [( Ca2+]i) simultaneously with force by a microfluorimetric method using fura-2, a calcium indicator, in canine coronary arterial smooth muscle cells. 2. The three K+ channel openers all produced a concentration-dependent reduction of [Ca2+]i in 5 and 30 mM KCl physiological salt solution (PSS) but failed to affect [Ca2+]i in 45 and 90 mM KCl-PSS. 3. Cromakalim only partly inhibited (-45%) the 30 mM KCl-induced contractures, whereas pinacidil and nicorandil nearly abolished contractions produced by 45 mM, 90 mM and 30 mM KCl-PSS. 4. Tetrabutylammonium (TBA), a nonselective K+ channel blocker, or glibenclamide, a supposed adenosine 5'-triphosphate (ATP)-sensitive K+ channel blocker, abolished the reduction of [Ca2+]i caused by the three K+ channel openers and the relaxant effect of cromakalim, whereas they only slightly attenuated the relaxant effects of pinacidil and nicorandil. 5. The increase in [Ca2+]i produced by 45 or 90 mM KCl-PSS in the presence of pinacidil or nicorandil was abolished by 10(-5) M verapamil, indicating that the increase in [Ca2+]i was caused by the influx of extracellular Ca2+ and that pinacidil and nicorandil did not affect the voltage-dependent Ca2+ channel directly. 6. The [Ca2+]i-force relationship in the presence of cromakalim was not distinguishable from that of control. 7. The [Ca2+]i-force curve was shifted to the right by pinacidil and nicorandil. 8. These results show that cromakalim is a more specific K+ channel opener than pinacidil and nicorandil, and that vasodilatation produced by cromakalim in this study is predominantly a result of a reduction of [Ca2+]i due to the closure of voltage-dependent Ca21 channels by hyperpolarization. In contrast, additional mechanisms are involved in the vasodilator actions of pinacidil and nicorandil. One of these is related to a reduction in the sensitivity of contractile proteins to Ca2 . The latter mechanism of nicorandil is akin to that of nitroglycerin. K+ channels opened by these K+ channel openers may be ATP-sensitive ones which are blocked by glibenclamide.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2149290      PMCID: PMC1917636          DOI: 10.1111/j.1476-5381.1990.tb12106.x

Source DB:  PubMed          Journal:  Br J Pharmacol        ISSN: 0007-1188            Impact factor:   8.739


  42 in total

1.  Circumstantial evidence for increased potassium conductance of membrane of cardiac muscle by 2-nicotinamidoethyl nitrate (SG-75).

Authors:  T Yanagisawa; K Satoh; N Taira
Journal:  Jpn J Pharmacol       Date:  1979-10

2.  Glyburide blocks the relaxation response to BRL 34915 (cromakalim), minoxidil sulfate and diazoxide in vascular smooth muscle.

Authors:  R J Winquist; L A Heaney; A A Wallace; E P Baskin; R B Stein; M L Garcia; G J Kaczorowski
Journal:  J Pharmacol Exp Ther       Date:  1989-01       Impact factor: 4.030

3.  cGMP and cAMP inhibit tension development in skinned coronary arteries.

Authors:  G Pfitzer; F Hofmann; J DiSalvo; J C Rüegg
Journal:  Pflugers Arch       Date:  1984-07       Impact factor: 3.657

4.  Pharmacological estimation of drug-receptor dissociation constants. Statistical evaluation. I. Agonists.

Authors:  R B Parker; D R Waud
Journal:  J Pharmacol Exp Ther       Date:  1971-04       Impact factor: 4.030

Review 5.  Tetraethylammonium ions and the potassium permeability of excitable cells.

Authors:  P R Stanfield
Journal:  Rev Physiol Biochem Pharmacol       Date:  1983       Impact factor: 5.545

6.  Effect of 2-nicotinamidethyl nitrate (SG-75) on the membrane potential of left atrial muscle fibres of the dog. Increase in potassium conductance.

Authors:  T Yanagisawa; N Taira
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1980-05       Impact factor: 3.000

7.  N''-cyano-N-4-pyridyl-N'-1,2,2-trimethylpropylguanidine, monohydrate (P 1134): a new, potent vasodilator.

Authors:  E Arrigoni-Martelli; C K Nielsen; U B Olsen; H J Petersen
Journal:  Experientia       Date:  1980-04-15

8.  Cyclic GMP as possible mediator of coronary arterial relaxation by nicorandil (SG-75).

Authors:  S Holzmann
Journal:  J Cardiovasc Pharmacol       Date:  1983 May-Jun       Impact factor: 3.105

9.  Relationship between relaxation and cyclic GMP formation caused by nicorandil in canine mesenteric artery.

Authors:  M Endoh; N Taira
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1983-05       Impact factor: 3.000

10.  Vasodilating actions of 2-nicotinamidoethyl nitrate on porcine and guinea-pig coronary arteries.

Authors:  K Furukawa; T Itoh; M Kajiwara; K Kitamura; H Suzuki; Y Ito; H Kuriyama
Journal:  J Pharmacol Exp Ther       Date:  1981-07       Impact factor: 4.030

View more
  14 in total

1.  The effects of a novel vasodilator, LP-805, on cytosolic Ca2+ concentrations and on tension in rabbit isolated femoral arteries.

Authors:  M Ushio-Fukai; K Hirano; H Kanaide
Journal:  Br J Pharmacol       Date:  1994-12       Impact factor: 8.739

2.  The mechanism of acidic pH-induced contraction in aortae from SHR and WKY rats enhanced by increasing blood pressure.

Authors:  K Furukawa; J Komaba; H Sakai; Y Ohizumi
Journal:  Br J Pharmacol       Date:  1996-06       Impact factor: 8.739

3.  Mechanisms of vasorelaxation induced by eicosapentaenoic acid (20:5n-3) in WKY rat aorta.

Authors:  M B Engler; M M Engler; A Browne; Y P Sun; R Sievers
Journal:  Br J Pharmacol       Date:  2000-12       Impact factor: 8.739

4.  Effects of the novel potassium channel opener, UR-8225, on contractile responses in rat isolated smooth muscle.

Authors:  F Perez-Vizcaino; O Casis; R Rodriguez; L A Gomez; J Garcia Rafanell; J Tamargo
Journal:  Br J Pharmacol       Date:  1993-11       Impact factor: 8.739

Review 5.  Nicorandil. A review of its pharmacology and therapeutic efficacy in angina pectoris.

Authors:  J Frampton; M M Buckley; A Fitton
Journal:  Drugs       Date:  1992-10       Impact factor: 9.546

6.  Levcromakalim-induced modulation of membrane potassium currents, intracellular calcium and mechanical activity in rat mesenteric artery.

Authors:  D N Criddle; I A Greenwood; A H Weston
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1994-04       Impact factor: 3.000

7.  Hyperpolarization induced by K+ channel openers inhibits Ca2+ influx and Ca2+ release in coronary artery.

Authors:  T Yanagisawa; T Yamagishi; Y Okada
Journal:  Cardiovasc Drugs Ther       Date:  1993-08       Impact factor: 3.727

8.  Characteristics of the contractile response of rabbit aorta produced by cromakalim in calcium-free solution.

Authors:  S Duty; A H Weston
Journal:  Br J Pharmacol       Date:  1992-12       Impact factor: 8.739

9.  K+ channel openers, cromakalim and Ki4032, inhibit agonist-induced Ca2+ release in canine coronary artery.

Authors:  T Yamagishi; T Yanagisawa; N Taira
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1992-12       Impact factor: 3.000

10.  Differential antagonism by glibenclamide of the relaxant effects of cromakalim, pinacidil and nicorandil on canine large coronary arteries.

Authors:  K Satoh; H Yamada; N Taira
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1991-01       Impact factor: 3.000

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.